Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer
Mark N. Adams(Queensland University of Technology), Kenneth J. O’Byrne(Trinity College Dublin)
Cited by 84
Related Papers
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer
|Molecular Cancer|2015|80
The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2
|PLoS ONE|2011|52
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor
|International Journal of Molecular Medicine|2012|39
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy
|Communications Biology|2021|26